Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Richard Junghans, PhD, MD, Roger Williams Medical Center
ClinicalTrials.gov Identifier:
NCT01723306
First received: November 1, 2012
Last updated: June 20, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)